EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The dual-specificity kinase DYRK1A interacts with the Hepatitis B virus genome and regulates the production of viral RNA

Florentin Pastor, Emilie Charles, Chiara Di Vona, Maëlys Chapelle, Michel Rivoire, Guillaume Passot, Benoit Chabot, Susana de la Luna iD, Julie Lucifora, David Durantel, Anna Salvetti iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0311655 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Florentin Pastor und 10 weiteren Autor:innen. Beteiligte Einrichtung: International Center for Research in Infectiology (CIRI), INSERM U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, ENS de Lyon, Lyon, France. Hauptthemen laut MEDLINE: Dyrk Kinases, Protein Serine-Threonine Kinases, Protein-Tyrosine Kinases, Hepatitis B virus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut National de la Santé et de la Recherche Médicale, the Centre National de la Recherche Scientifique, Université Lille 1 - Sciences et Technologies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The genome of Hepatitis B virus (HBV) persists in infected hepatocytes as a nuclear episome (cccDNA) that is responsible for the transcription of viral genes and viral rebound, following antiviral treatment arrest in chronically infected patients. There is currently no clinically approved therapeutic strategy able to efficiently target cccDNA (Lucifora J 2016). The development of alternative strategies aiming at permanently abrogating HBV RNA production requires a thorough understanding of cccDNA transcriptional and post-transcriptional regulation. In a previous study, we discovered that 1C8, a compound that inhibits the phosphorylation of some cellular RNA-binding proteins, could decrease the level of HBV RNAs. Here, we aimed at identifying kinases responsible for this effect. Among the kinases targeted by 1C8, we focused on DYRK1A, a dual-specificity kinase that controls the transcription of cellular genes by phosphorylating transcription factors, histones, chromatin regulators as well as RNA polymerase II. The results of a combination of genetic and chemical approaches using HBV-infected hepatocytes, indicated that DYRK1A positively regulates the production of HBV RNAs. In addition, we found that DYRK1A associates with cccDNA, and stimulates the production of HBV nascent RNAs. Finally, reporter gene assays showed that DYRK1A up-regulates the activity of the HBV enhancer 1/X promoter in a sequence-dependent manner. Altogether, these results indicate that DYRK1A is a proviral factor that may participate in the HBV life cycle by stimulating the production of HBx, a viral factor absolutely required to trigger the complete cccDNA transcriptional program.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dyrk KinasesProtein Serine-Threonine KinasesProtein-Tyrosine KinasesHepatitis B virusRNA, ViralGenome, ViralHumansHepatocytesHep G2 CellsVirus ReplicationDNA, CircularViral Regulatory and Accessory ProteinsTrans-Activators

Substanzen

Dyrk KinasesProtein Serine-Threonine KinasesProtein-Tyrosine KinasesRNA, ViralDNA, Circularhepatitis B virus X proteinViral Regulatory and Accessory ProteinsTrans-Activators

Autor:innen und Institutionen

  • International Center for Research in Infectiology (CIRI), INSERM U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, ENS de Lyon, Lyon, France.
  • Genome Biology Program, Center for Genomic Regulation (CRG), and CIBER of Rare Diseases, Barcelona, Spain.
  • Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
  • INSERM U1032, Centre Léon Bérard (CLB), Lyon, France.
  • Service de Chirurgie Générale et Oncologique, Hôpital Lyon Sud, Hospices Civils de Lyon Et CICLY, EA3738, Université Lyon 1, Lyon, France.
  • Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada.

ORCID-Profile: Susana de la Luna, Anna Salvetti

Förderung

  • Institut National de la Santé et de la Recherche Médicale
  • the Centre National de la Recherche Scientifique
  • Université Lille 1 - Sciences et Technologies
  • Ministerio de Ciencia, Innovación y Universidades
  • Departament de Salut, Generalitat de Catalunya
  • Agence Nationale de Recherche sur le Sida et les hépatites virales
  • Canadian Institute for Health Research

Zitieren

APA

Pastor, F., Charles, E., Di Vona, C., Chapelle, M., Rivoire, M., Passot, G., Chabot, B., de la Luna, S., Lucifora, J., Durantel, D., & Salvetti, A. (2024). The dual-specificity kinase DYRK1A interacts with the Hepatitis B virus genome and regulates the production of viral RNA. PLOS ONE. https://doi.org/10.1371/journal.pone.0311655

Vancouver

Pastor F, Charles E, Di Vona C, Chapelle M, Rivoire M, Passot G, et al. The dual-specificity kinase DYRK1A interacts with the Hepatitis B virus genome and regulates the production of viral RNA. PLOS ONE. 2024. doi:10.1371/journal.pone.0311655

BibTeX
@article{Pastor2024,
  author = {Pastor, Florentin and Charles, Emilie and Di Vona, Chiara and Chapelle, Maëlys and Rivoire, Michel and Passot, Guillaume and Chabot, Benoit and de la Luna, Susana and Lucifora, Julie and Durantel, David and Salvetti, Anna},
  title = {The dual-specificity kinase DYRK1A interacts with the Hepatitis B virus genome and regulates the production of viral RNA},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0311655}
}
Kostenlos starten →